Page last updated: 2024-11-12

lamellarin alpha

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

lamellarin alpha: antioxidant from the Indian ascidian Didemnum obscurum; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID11477790
CHEMBL ID1928864
MeSH IDM0472037

Synonyms (3)

Synonym
CHEMBL1928864
lamellarin alpha
7-hydroxy-12-(3-hydroxy-4-methoxyphenyl)-8,16,17-trimethoxy-4-oxa-1-azapentacyclo[11.8.0.02,11.05,10.014,19]henicosa-2(11),5,7,9,12,14,16,18,20-nonaen-3-one
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (3)

Assay IDTitleYearJournalArticle
AID635408Cellular uptake in human HeLa cells expressing CD4 at 100 uM after 24 hrs by confocal laser scanning microscopy analysis in presence of methanol2011Bioorganic & medicinal chemistry, Dec-15, Volume: 19, Issue:24
Synthesis, structure-activity relationships, and mechanism of action of anti-HIV-1 lamellarin α 20-sulfate analogues.
AID635405Antiviral activity against LacZ-containing HIV1 in COS7 cells expressing HXB2 Env, R8.91, and pTY-EFnLacZ assessed as reduction of viral vector infection into human HeLa cells expressing CD4 after 2 days using 5-bromo-4-chloro-3-indolyl-beta-D-galactopyra2011Bioorganic & medicinal chemistry, Dec-15, Volume: 19, Issue:24
Synthesis, structure-activity relationships, and mechanism of action of anti-HIV-1 lamellarin α 20-sulfate analogues.
AID635407Cellular uptake in human HeLa cells expressing CD4 at 100 uM after 24 hrs by confocal laser scanning microscopy analysis2011Bioorganic & medicinal chemistry, Dec-15, Volume: 19, Issue:24
Synthesis, structure-activity relationships, and mechanism of action of anti-HIV-1 lamellarin α 20-sulfate analogues.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (60.00)29.6817
2010's1 (20.00)24.3611
2020's1 (20.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.87

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.87 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.66 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.87)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]